The U.S. Food and Drug Administration(FDA) has reportedly authorized the use of blood plasma from patients who have recovered from COVID-19 as a treatment for the illness. According to Reuters, the FDA said on Saturday that early evidence suggests blood plasma can decrease mortality and improve the health of patients when administered in the first...Read More
